FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012081013> ?p ?o ?g. }

• W2012081013 endingPage "64" @default.
• W2012081013 startingPage "64" @default.
• W2012081013 abstract "<h3>Background:</h3> There is limited information regarding the usefulness of primary antifungal prophylaxis in patients with advanced human immunodeficiency virus (HIV) disease. <h3>Objective:</h3> To evaluate the efficacy and safety of oral fluconazole treatment for the prevention of systemic fungal diseases related to the acquired immunodeficiency syndrome. <h3>Methods:</h3> We evaluated the clinical records of more than 1300 HIV-infected patients followed up for 6 years to identify subjects with a CD4⁺lymphocyte count less than 0.20 ×10⁹/L (200/μL) and no prior systemic fungal disease. We compared 128 patients who received oral fluconazole (100 mg/d every third week) with 121 subjects who received no antifungal treatment. <h3>Main Outcome Measures:</h3> The occurrence of visceral mycoses or death was considered an end point. The frequency of esophageal candidiasis and extrapulmonary cryptococcosis and their related clinical and laboratory features, as well as overall patient survival, were assessed and compared between the 2 study groups. <h3>Results:</h3> Subjects not treated with fluconazole experienced a significantly higher incidence of systemic mycoses than patients who received fluconazole: 28.4 vs 8.8 cases per 100 patient-years (<i>P</i><.001). Fluconazole treatment was more effective in preventing esophageal candidiasis than cryptococcosis and was more effective in subjects with a CD4⁺cell count less than 0.10×10⁹/L Moreover, fungal complications occurred later and were associated with a significantly lower CD4⁺cell count among treated vs untreated patients, while the duration of antiretroviral therapy did not play a significant role. Although mortality rates were similar in the 2 study groups, the fatal outcome of disease was less frequently caused by a fungal disease in subjects who underwent fluconazole prophylaxis. Fluconazole had a favorable tolerability profile. <h3>Conclusions:</h3> In our experience, primary fluconazole prophylaxis proved safe and effective in the prevention of systemic candidiasis and cryptococcosis in patients with advanced HIV disease but it did not improve overall survival. Prospective controlled trials are advisable to confirm efficacy, to find the drug of choice and its best dosage and schedule of administration, to identify patient subgroups showing the most favorable cost-benefit ratios, and to evaluate the effects on overall life expectancy and the risk of emergence and spread of antifungal drug resistance. Arch Intern Med. 1997;157:64-69" @default.
• W2012081013 created "2016-06-24" @default.
• W2012081013 creator A5006204124 @default.
• W2012081013 creator A5026311261 @default.
• W2012081013 creator A5051980640 @default.
• W2012081013 creator A5080694994 @default.
• W2012081013 date "1997-01-13" @default.
• W2012081013 modified "2023-09-23" @default.
• W2012081013 title "Fluconazole as Prophylaxis Against Fungal Infection in Patients With Advanced HIV Infection" @default.
• W2012081013 cites W1967866045 @default.
• W2012081013 cites W1969122368 @default.
• W2012081013 cites W1984513537 @default.
• W2012081013 cites W1998202789 @default.
• W2012081013 cites W2011613010 @default.
• W2012081013 cites W2018134360 @default.
• W2012081013 cites W2027563386 @default.
• W2012081013 cites W2039904074 @default.
• W2012081013 cites W2043979191 @default.
• W2012081013 cites W2047418663 @default.
• W2012081013 cites W2049243163 @default.
• W2012081013 cites W2078091919 @default.
• W2012081013 cites W2078589816 @default.
• W2012081013 cites W2079764502 @default.
• W2012081013 cites W2083354393 @default.
• W2012081013 cites W2132310675 @default.
• W2012081013 cites W2316588957 @default.
• W2012081013 cites W2316989402 @default.
• W2012081013 cites W2325378476 @default.
• W2012081013 cites W2339763729 @default.
• W2012081013 cites W2418572412 @default.
• W2012081013 cites W73811271 @default.
• W2012081013 cites W2502179184 @default.
• W2012081013 doi "https://doi.org/10.1001/archinte.1997.00440220068009" @default.
• W2012081013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8996042" @default.
• W2012081013 hasPublicationYear "1997" @default.
• W2012081013 type Work @default.
• W2012081013 sameAs 2012081013 @default.
• W2012081013 citedByCount "25" @default.
• W2012081013 countsByYear W20120810132012 @default.
• W2012081013 countsByYear W20120810132013 @default.
• W2012081013 countsByYear W20120810132014 @default.
• W2012081013 countsByYear W20120810132018 @default.
• W2012081013 countsByYear W20120810132020 @default.
• W2012081013 crossrefType "journal-article" @default.
• W2012081013 hasAuthorship W2012081013A5006204124 @default.
• W2012081013 hasAuthorship W2012081013A5026311261 @default.
• W2012081013 hasAuthorship W2012081013A5051980640 @default.
• W2012081013 hasAuthorship W2012081013A5080694994 @default.
• W2012081013 hasConcept C120665830 @default.
• W2012081013 hasConcept C121332964 @default.
• W2012081013 hasConcept C126322002 @default.
• W2012081013 hasConcept C141071460 @default.
• W2012081013 hasConcept C16005928 @default.
• W2012081013 hasConcept C203014093 @default.
• W2012081013 hasConcept C2779413141 @default.
• W2012081013 hasConcept C2779548794 @default.
• W2012081013 hasConcept C2780651595 @default.
• W2012081013 hasConcept C2780727368 @default.
• W2012081013 hasConcept C2780908437 @default.
• W2012081013 hasConcept C2781005205 @default.
• W2012081013 hasConcept C3013748606 @default.
• W2012081013 hasConcept C61511704 @default.
• W2012081013 hasConcept C71924100 @default.
• W2012081013 hasConcept C90924648 @default.
• W2012081013 hasConceptScore W2012081013C120665830 @default.
• W2012081013 hasConceptScore W2012081013C121332964 @default.
• W2012081013 hasConceptScore W2012081013C126322002 @default.
• W2012081013 hasConceptScore W2012081013C141071460 @default.
• W2012081013 hasConceptScore W2012081013C16005928 @default.
• W2012081013 hasConceptScore W2012081013C203014093 @default.
• W2012081013 hasConceptScore W2012081013C2779413141 @default.
• W2012081013 hasConceptScore W2012081013C2779548794 @default.
• W2012081013 hasConceptScore W2012081013C2780651595 @default.
• W2012081013 hasConceptScore W2012081013C2780727368 @default.
• W2012081013 hasConceptScore W2012081013C2780908437 @default.
• W2012081013 hasConceptScore W2012081013C2781005205 @default.
• W2012081013 hasConceptScore W2012081013C3013748606 @default.
• W2012081013 hasConceptScore W2012081013C61511704 @default.
• W2012081013 hasConceptScore W2012081013C71924100 @default.
• W2012081013 hasConceptScore W2012081013C90924648 @default.
• W2012081013 hasIssue "1" @default.
• W2012081013 hasLocation W20120810131 @default.
• W2012081013 hasLocation W20120810132 @default.
• W2012081013 hasOpenAccess W2012081013 @default.
• W2012081013 hasPrimaryLocation W20120810131 @default.
• W2012081013 hasRelatedWork W1978771427 @default.
• W2012081013 hasRelatedWork W2012081013 @default.
• W2012081013 hasRelatedWork W2038411118 @default.
• W2012081013 hasRelatedWork W2057717851 @default.
• W2012081013 hasRelatedWork W2104154636 @default.
• W2012081013 hasRelatedWork W2122887554 @default.
• W2012081013 hasRelatedWork W2167867126 @default.
• W2012081013 hasRelatedWork W2339763729 @default.
• W2012081013 hasRelatedWork W2425854497 @default.
• W2012081013 hasRelatedWork W75140730 @default.
• W2012081013 hasVolume "157" @default.
• W2012081013 isParatext "false" @default.
• W2012081013 isRetracted "false" @default.

• next